Ulcerative
Colitis (UC) is an inflammatory bowel disease (IBD) characterized by
long-lasting inflammation and ulcers (sores) in the lining of the colon. UC
commonly affects teenagers and young adults, and can result in poor development
and growth; however, the disease can also occur in children and older
individuals. Unlike Crohn's disease (CD), another form of IBD that has similar
symptoms to UC but can occur anywhere in the digestive tract and features
ulceration deep into the tissues, UC is limited to the colon and has less
frequent complications.
GlobalData's epidemiological
forecast for the diagnosed incidence, diagnosed prevalence, undiagnosed
prevalence, and total prevalence of UC in the 7MM is supported by nationally
representative, country-specific studies published in peer-reviewed journals of
national healthcare databases and registries. In addition, to improve the
comparability of the forecast diagnosed incident and diagnosed prevalent cases
of UC across markets, GlobalData epidemiologists used sources that provided
uniform diagnostic criteria for these subcategories.
In the 7MM, the diagnosed
incident cases of UC are expected to increase from 94,303 cases in 2016 to
108,428 cases in 2026, at an Annual Growth Rate (AGR) of 1.5%. The US will have
the highest number of diagnosed incident cases of UC over the forecast period,
while Spain will have the lowest. In the 7MM, the diagnosed prevalent cases of
UC are expected to increase from 1,737,130 cases in 2016 to 1,867,305 cases in
2026, at an AGR of 0.75%. The US will have the highest number of diagnosed
prevalent cases of UC over the forecast period, while Spain will have the
lowest.
The Ulcerative Colitis (UC) Epidemiology Forecast Report provides an
overview of the risk factors and global trends of UC in the seven major markets
(7MM: US, France, Germany, Italy, Spain, UK, and Japan).
This report also includes a
10-year epidemiological forecast for the diagnosed incident cases, diagnosed
prevalent cases, undiagnosed prevalent cases, and total prevalent cases (both
diagnosed and undiagnosed) of UC, segmented by sex and age (starting at ages
0-9 years and ending at ages 80 years and older) in these markets. The
diagnosed incident cases are further segmented by stage at diagnosis and
severity grading. The diagnosed prevalent cases are further segmented by
severity grading. Additionally, autoimmune comorbidities, colectomy due to
failure of medical management, and mortality due to complications of UC among
the diagnosed prevalent cases of UC are also included in this analysis.
Furthermore, the report includes diagnosed incident cases and diagnosed
prevalent cases of indeterminate colitis (IC) for both sexes and all ages in
the 7MM.
The Ulcerative Colitis
epidemiology forecast report is written and developed by Masters- and PhD-level
epidemiologists. The Epidemiology Forecast Report is in-depth, high quality,
transparent, and market-driven, providing expert analysis of disease trends in
the 7MM.
The Ulcerative Colitis (UC) Epidemiology Forecast report will allow
you to develop business strategies by understanding the trends shaping and
driving the global UC market. Quantify patient populations in the global UC
market to improve product design, pricing, and launch plans. Organize sales and
marketing efforts by identifying the age groups and sex that present the best
opportunities for UC therapeutics in each of the markets covered. Understand
magnitude of UC population by severity, stage at diagnosis, comorbidities, and
other clinically relevant segmentations.
To know more, click on the link below:-
Related Reports:-
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
